Global Autologous Cell Therapy Market Trajectory & Analytics Report 2021: Market to Reach $29.3 Billion by 2027 – Bone Marrow Segment to Account for $17.1 Billion – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Autologous Cell Therapy – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Global Autologous Cell Therapy Market to Reach $29.3 Billion by 2027

Amid the COVID-19 crisis, the global market for Autologous Cell Therapy estimated at US$8.9 Billion in the year 2020, is projected to reach a revised size of US$29.3 Billion by 2027, growing at a CAGR of 18.6% over the analysis period 2020-2027.

Bone Marrow, one of the segments analyzed in the report, is projected to record a 18.3% CAGR and reach US$17.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Epidermis segment is readjusted to a revised 20.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $2.6 Billion, While China is Forecast to Grow at 18.3% CAGR

The Autologous Cell Therapy market in the U.S. is estimated at US$2.6 Billion in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$5.2 Billion by the year 2027 trailing a CAGR of 18.3% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 16.6% and 15.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 13% CAGR.

Other Sources Segment to Record 17.2% CAGR

In the global Other Sources segment, USA, Canada, Japan, China and Europe will drive the 17.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.1 Billion in the year 2020 will reach a projected size of US$3.3 Billion by the close of the analysis period.

China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.4 Billion by the year 2027.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• Influencer Market Insights
• World Market Trajectories
• Impact of Covid-19 and a Looming Global Recession

III. MARKET ANALYSIS

IV. COMPETITION

• (Total 42 Featured):

  • BioTime, Inc.
  • Brainstorm Cell Therapeutics, Inc.
  • Caladrius Biosciences, Inc.
  • Fibrocell Science, Inc.
  • Opexa Therapeutics, Inc.
  • Pharmicell Co., Ltd.
  • Regeneus Ltd.
  • TiGenix NV
  • TxCell S.A.
  • U.S. Stem Cell, Inc.
  • Vericel Corporation

For more information about this report visit https://www.researchandmarkets.com/r/57ibf3

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900